DWS
MYGN icon

Dynamic Wealth Strategies’s Myriad Genetics MYGN Stock Holding History

Dynamic Wealth Strategies’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-276
Closed -$2.45K – 242
2025
Q1 		$2.45K Buy
+276
New +$3.31K ﹤0.01% 221
2024
Q4 		– Sell
-276
Closed -$8K – 174
2024
Q3 		$8K Hold
276
– – 0.01% 206
2024
Q2 		$7K Hold
276
– – 0.01% 212
2024
Q1 		$6K Hold
276
– – 0.01% 225
2023
Q4 		$5.28K Buy
+276
New +$4.78K ﹤0.01% 227

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Dynamic Wealth Strategies's MYGN Position: Q2 2025 in Review

Dynamic Wealth Strategies sold out of Myriad Genetics (MYGN) in Q2 2025, closing a stake of 276 shares — an estimated $2.45K sold.

Dynamic Wealth Strategies first reported a position in MYGN in Q4 2023 and held it in 5 quarters. The position peaked at $8K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • Dynamic Wealth Strategies reported no remaining Myriad Genetics position as of Q2 2025 after selling out during the quarter.
  • Dynamic Wealth Strategies sold 276 Myriad Genetics shares in Q2 2025, an estimated $2.45K.
  • Dynamic Wealth Strategies first reported a position in Myriad Genetics in Q4 2023 and held it in 5 quarters.
  • Dynamic Wealth Strategies's Myriad Genetics position peaked at $8K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2025, filed 13 Aug 2025.